As bioscience, manufacturing, medical device, and IT industries continue to grow, we find that these fields all over the world have begun to converge into a new generation of healthcare solutions.
BioForward's Biohealth Summit provided a platform for Wisconsin to shine and boost our reputation as a world leader in integrated health solutions from bioscience and therapeutics to device/diagnostics and digital health. This Summit highlighted discovering the convergence of our many, diverse sectors of science, technology, and healthcare.
Mark Freitas is Managing Director, Patient Health & Competitive Center of Excellence within Accenture Strategy. Mark focuses on value and growth strategies at the intersection between health and life science. Mark has over 15 years of experience across a wide spectrum of health and life science. Prior to Accenture, Mark led the Corporate Strategy and Development group for ARIAD Pharmaceuticals and prior to that was as an attorney responsible for building the Food and Drug practice at the international law firm of Wilson Elser.
Mark Freitas is Managing Director, Patient Health & Competitive Center of Excellence within Accenture Strategy.His keynote will focus on the need for healthcare and related industries to respond to the shift from volume to value based payments, including new business models such as Lean Innovators, Around-the-Patient Innovators, Value Innovators, and New Health Digitals. These ideas are expanded in the book Healthcare Disrupted: Next Generation Business Models and Strategies, which was written by his Accenture colleagues.
Wisconsin is a world leader in manufacturing, and we have the expertise and resources to extend that reputation into biomanufacturing. Hear from leaders from industry and academia about how Wisconsin is leading the way in biomanufacturing, regenerative medicine, and stem cell technology. Our group will share ideas on how we can make Wisconsin a recognized, world-class Center of Biomanufacturing Excellence.The global biohealth industry is evolving at a rapid pace, and many of the companies fueling these changes with disruptive ideas and technology are located right here in Wisconsin. Our local innovators will share how their products, from software to sensors to devices, are changing healthcare.
Attracting talented individuals and getting them to stay is a problem of the highest priority at every company. Hear from award-winning, “Best Places to Work” in Wisconsin about how they have created corporate cultures that appeal to the most skilled and accomplished candidates in their fields.
From seed stage through exit, convertible debt to reverse merger, the investment strategy, source of funding, and structure of the deal is critical. This panel will focus on helping you think through the variety of options available to fund your company, and the key factors that influence success.
In 2015, BioForward launched the tradition of recognizing, on an annual basis, scientific and business achievements in biohealth. As we look to the future, we reflect back on the successes that have brought Wisconsin to be among the leaders in healthcare. Our recipients in 2015, captured Wisconsin’s broad impact on global human health, and additionally, their scientific and business contributions have had a significant impact on Wisconsin’s economy. Don’t miss the 2016 Biohealth Summit lunch as we recognize our 2016 awardees, highlighting their major contributions to Wisconsin and to our biohealth community.
Dr. James Thomson, Morgridge Institute
2016 Hector F. DeLuca Scientific Achievement Award Recipient
Dr. Thomson serves as Director of Regenerative Biology, at the Morgridge Institute for Research. In 2007, his lab reported (contemporaneously with Dr. Shinya Yamanaka) the first isolation of human induced pluripotent (iPS) stem cells. iPS cells have the basic properties of human ES cells but are derived from somatic cells rather than human embryos. Dr. Thomson, also founded Cellular Dynamics, a Madison, WI based company acquired by FUJIFILM in March 2015.
Ralph Kauten, Lucigen
2016 Biohealth Business Achievement Award Recipient
Ralph Kauten’s involvement in biotechnology started in 1979 at Promega Corporation followed by playing vital roles in PanVera Corporation, Mirus Bio Corporation, Quintessence Biosciences, Inc. and he currently serves as the CEO of Lucigen Corporation.
Wisconsin is currently a world leader in manufacturing, and we have the expertise and resources to extend that reputation into biomanufacturing. Hear from leaders in both academia and industry on how Wisconsin is leading the way in biomanufacturing, regenerative medicine, and stem cell technology and how we can make Wisconsin a recognized, world-class Center of Biomanufacturing Excellence. Discover how research institutions, biohealth companies, and manufacturing plants are collaborating across the state to explore the next frontier of medicine and manufacturing.
Many global leaders in technology have made the decision to devote resources and acquire new assets so they may enter and compete in a sometimes completely unexpected field, healthcare. We have gathered leaders from some of these companies to discuss why the decision was made to focus on healthcare, how easy or difficult that transition period has been, what they see in store for the future of healthcare, and how their company will lead in the creation of the next generation of healthcare solutions.
Hear from a panel of pharmaceutical experts on how understanding the needs of an empowered patient population is impacting everything from regulatory strategy and drug development to product commercialization and patient support
This session examines the new approaches and technology being used to study, detect, and treat cancer. Hear how global leaders in pharmaceuticals and digital health are collaborating with academic researchers, hospital systems, and the biohealth industry to uncover new paths to improving patient outcomes. We have the opportunity to hear from a cancer survivor about what “improved outcomes” truly mean to patients.
PhRMA to present their Economic Impact Study on Clinical Trials in Wisconsin as an introduction
Overture Center for the Arts is a stunning architectural landmark in the heart of Madison’s thriving cultural arts district. In addition to housing ten resident organizations and presenting more than 200 performances, art exhibitions, and educational and community events each year.
Overture Center for the Arts
201 State Street
Madison, WI 53703
Exploring the future of health solutions from basic research to life-changing technologies
Highlighting the value of the biohealth industry and its impact in the state of Wisconsin
Defining how Wisconsin is established in the future of biohealth and healthcare
Discussing local, national, and global trends in biohealth and healthcare
Outlining Wisconsin assets that map to these trends and convergence of multiple industries
Statewide collaborations, assets, and success stories of biohealth convergence in Wisconsin, i.e. manufacturing to medical de-vice sector